anti-HPV therapy (EPIcyte)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-HPV therapy (EPIcyte)
Drug Alias Nameanti-CD52 mAbs (EPIcyte)plantibodies (EPIcyte)STD prophylactic (EPIcyte)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCAMPATH-1 antigen inhibitors
TargetsCAMPATH-1 antigen
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEPIcyte Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEPIcyte Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A